HOME >> MEDICINE >> NEWS
Desperation drives patients

This release is also available in French, Spanish, German, and Italian.

Oncologists were urged to be more responsive to cancer patients who want to try alternative medicines. Speaking today (18 October 2002) at the European Society for Medical Oncology Congress in Nice, France, Professor Edzard Ernst from the Peninsula Medical School, Universities of Exeter & Plymouth, UK, said that a lack of openness to other forms of treatment is what drives people to alternative therapies. If they feel they cannot discuss it with their physician it can endanger their lives.

"Be open," said Professor Ernst. "People with cancer are desperate for treatment and will try anything. You would probably do the same!", he told delegates.

Many forms of complementary and alternative medicines are promoted as a prevention of cancer. There is little risk associated with garlic, green tea, phytoestrogens, and panax ginseng, although there is only weak evidence that they are effective.

More alarmingly, there is an increasing number of complementary and alternative therapies that claim to cure cancer, often supported by quasi-scientific data. Essiac, Di Bella therapy, Hoxley formula, mistletoe, and shark cartilage are a few examples of substances that can be dangerous to the patient.

Professor Ernst, who is director of complementary medicine at the medical school, carries out research to acquire much needed data on the efficacy and safety of alternative therapies. "Whether we love or hate them, we must answer the basic questions about complementary or alternative remedies," he said. Little is known about their interaction with conventional medicine and it can be tempting f
'"/>

Contact: Gracemarie Bricalli
gracemarie@esmo.org
41-91-973-1911
European Society for Medical Oncology
18-Oct-2002


Page: 1 2

Related medicine news :

1. Rutgers-developed biomaterial drives a technology transfer story toward success
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. Study finds that coordinating care of chronically ill patients does not increase liability
4. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
5. Optical technique identifies vulnerable plaques in cardiac patients
6. NHS target driven culture is failing patients
7. Cardiac deaths peak in sleep hours for patients with sleep apnea
8. Chronic fatigue patients show lower response to placebos
9. Depression linked to insomnia in HIV patients
10. Disfigured patients may be forced to forego surgery
11. Massive weight loss patients create mass appeal for body contouring procedures

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... ... It is vital for any lab to secure funding, and the best ... Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline analysis and ... a GLP (Good Laboratory Practice) fashion. , With features designed to simplify life in ...
(Date:12/7/2016)... San Fernando Valley, CA (PRWEB) , ... December 07, 2016 , ... ... Sculptra can be used in several ways to restore a more youthful appearance to ... doctors , now offer Sculptra, along with a variety of other treatments, to rejuvenate ...
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward ... comments on social media that offer a rare glimpse into the mind of those ... and New York Times bestselling author, has described people with ADHD as having “Ferrari ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in the blood associated ... appearing online in the journal Radiology. , Heart disease and brain disease exact a ... the rapidly aging population. Damage to both organs often occurs at a subclinical stage, ...
(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes and ... around the nation. What do they have in common? All have been affected by ... new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. , ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... DIEGO , Dec. 6, 2016  Arcturus ... RNA medicines company, announced today that it entered ... develop RNA-based therapeutics for the treatment of NASH ... wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer ... "Given Takeda,s long-standing commitment to and expertise ...
(Date:12/6/2016)... , Dec. 6, 2016  Regulus Therapeutics Inc. ... leading the discovery and development of innovative medicines ... candidates at its R&D day, held in ... RGLS5040, is an anti-miR targeting microRNA-27 (miR-27) for ... RGLS4326, is an anti-miR targeting microRNA-17 (miR-17) for ...
(Date:12/6/2016)... new study released today by the Alliance for Integrity ... Pricing Program will continue to expand at an unprecedented rate ... $23 billion in total purchases at the 340B price. This ... B drug reimbursement purchases over the next five years.      ... data on total drug purchases through 340B from 2005 to ...
Breaking Medicine Technology:
Cached News: